Poly(ADP-ribose) polymerase: a new therapeutic target?

Area of Science:

• Biochemistry
• Molecular Biology
• Critical Care Medicine

Background:

• Poly(ADP-ribose) polymerase (PARP) is a nuclear enzyme crucial for DNA repair and gene regulation.
• Emerging research highlights PARP's significant role in cellular responses to cellular stress and damage.

Purpose of the Study:

• To review current literature on the involvement of PARP in the pathogenesis of critical illness.
• To explore PARP's function in cellular survival and death pathways.

Main Methods:

• Literature review of studies investigating PARP's role in critical illness.
• Analysis of data on PARP activation, its consequences, and the effects of its inhibition.

Main Results:

• PARP activation, triggered by oxidative DNA damage, depletes cellular energy, leading to dysfunction.
• Activated PARP promotes cell death pathways and exacerbates inflammatory responses.
• PARP plays a key role in cardiovascular dysfunction and multiple organ failure during circulatory shock.

Conclusions:

• PARP is a critical regulator of cell fate in critical illness.
• Inhibition of PARP demonstrates protective effects in experimental models of circulatory shock.
• PARP represents a promising therapeutic target for critical illness management.